In this section will gather urogynaecology-related information drawn from a variety of sources. This could include scientific publications, documents from other associations or organisations, or news reports that are pertinent to the field. The aim is to help the urogynaecological community stay up-to-date on developments that impact the field.
Conjoint Urological Society of Australia and New Zealand (USANZ) and Urogynaecological Society of Australasia (UGSA) Guidelines on the management of adult non-neurogenic overactive bladder.
Download guideline here
PELVIC MESH INFORMATION
There has been a great deal of interest and comment about the use of mesh as part of the surgical treatment of vaginal prolapse and urinary incontinence. There is currently a Senate Inquiry into the Number of women in Australia who have had transvaginal mesh implants and related matters which is due to report its findings by 30 November 2017.
Bellow is a range of information relating to pelvic mesh including information from UGSA, patient letters, and UGSA's submission to the Senate Inquiry.
UGSA Submission to Senate Inquiry into TransVaginal Mesh Implants
On 15 February 2017 the Senate opened an inquiry on The number of women in Australia who have had transvaginal mesh implants and related matters. The date for submissions has been extended until 30 June 2017. The reporting date is 30 November 2017.
Click on link below to access UGSA's submission.
Further details on the Senate Inquiry can be found on the Parliament of Australia Website.
See a list below of the the 2015 European, New Zealand and Scottish reports on transvaginal tapes and meshes:
UGSA Statement on vaginal mesh prolapse repair
Read statement here.
The TGA has published updated information regarding urogynaecological surgical mesh implants.
The TGA's statement can be found here.
UGSA Mid-Urethral Sling Statement
Read full statement here.
Article on Teaching Vaginal Mesh Surgery - Dr Malcolm Frazer
Read full article here.
RANZCOG Media Release on Vaginal Mesh
Read full release here.